EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Insulin/IGF signaling in islet biology and its therapeutic implications

Hyunki Kim iD, Rohit N Kulkarni iD

Endocrine Reviews · 16.09.2026 · 47 (5) · 637-665

DOI: 10.1210/endrev/bnag014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine Reviews, online erschienen am 20.05.2026. Verfasst von Hyunki Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section of Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Signal Transduction, Insulin, Islets of Langerhans, Insulin-Like Peptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 348 Literaturangaben. Gefördert von: National Research Foundation of Korea (NRF), Ministry of Education, Diabetes Research and Wellness Foundation Endowed Chair.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The islet of Langerhans (or pancreatic islet) is a unique endocrine organ that secretes multiple hormones that in turn orchestrate energy metabolism in humans. As in other metabolic organs, growth factor(s) regulate functional islet mass to maintain whole-body glucose homeostasis. Over the past decades, a large body of evidence has pointed to insulin and insulin-like growth factors (IGFs) as playing central roles in modulating diverse aspects of islet cell biology and a dysregulated insulin/IGF pathway has come to be recognized as a pathophysiological hallmark of type 2 diabetes. Several recent reports, especially focused on β-cells, highlight emerging aspects of insulin/IGF signaling, including a role for RNA modifications, transcriptional regulation by nuclear insulin and IGF-1 receptors, and the discovery of an insulin inhibitory receptor, inceptor. In this review, we summarize the functional roles of insulin/IGF signaling in regulating islet cell biology, the short- and long-term effects of insulin therapy in humans, and propose potential strategies to maximize the beneficial effects of insulin action in islets to counter diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionInsulinIslets of LangerhansInsulin-Like PeptidesDiabetes Mellitus, Type 2SomatomedinsHumansAnimals

Stichwörter der Autor:innen

diabeteshuman pancreatic islet/β-cellinceptorincretinsinsulin therapyinsulin/IGF signaling

Substanzen

InsulinInsulin-Like PeptidesSomatomedins

Autor:innen und Institutionen

  • Section of Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA 02115, USA.
  • Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
  • Harvard Stem Cell Institute, Harvard Medical School, Cambridge, MA 02138, USA.

ORCID-Profile: Hyunki Kim, Rohit N Kulkarni

Förderung

  • National Research Foundation of Korea (NRF)
  • Ministry of Education
  • Diabetes Research and Wellness Foundation Endowed Chair
  • NIDDK NIH HHS
  • Joslin Diabetes Research Center (DRC) Cores
  • NIH

Zitieren

APA

Kim, H., & Kulkarni, R. N. (2026). Insulin/IGF signaling in islet biology and its therapeutic implications. Endocrine Reviews, 47(5), 637-665. https://doi.org/10.1210/endrev/bnag014

Vancouver

Kim H, Kulkarni RN. Insulin/IGF signaling in islet biology and its therapeutic implications. Endocrine Reviews. 2026;47(5):637-665. doi:10.1210/endrev/bnag014

BibTeX
@article{Kim2026,
  author = {Kim, Hyunki and Kulkarni, Rohit N},
  title = {Insulin/IGF signaling in islet biology and its therapeutic implications},
  journal = {Endocrine Reviews},
  year = {2026},
  volume = {47},
  number = {5},
  pages = {637--665},
  doi = {10.1210/endrev/bnag014}
}
Kostenlos starten →